NCT02486965 (DOUFISPORT) is a NA clinical trial of thermode (TSA-II model) in Fibromyalgia, sponsored by University Hospital, Brest.

Who is sponsoring NCT02486965?

NCT02486965 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT02486965?

Interventions in NCT02486965: thermode (TSA-II model), Adapted Physical Activity, Physical activity.

What condition does NCT02486965 study?

NCT02486965 studies Fibromyalgia.

Is NCT02486965 still recruiting?

NCT02486965 is currently completed. Last updated 22 April 2022.

Last reviewed 2022-04-22 · How we verify

NCT02486965: DOUFISPORT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects

Completed NA Last updated 22 April 2022

What this trial tests

NA trial testing thermode (TSA-II model) in Fibromyalgia in 60 participants. Completed in 21 October 2021.

Timeline

7 October 2015

Primary endpoint
21 February 2019

21 October 2021

Quick facts

Lead sponsor	University Hospital, Brest
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	7 October 2015
Primary completion	21 February 2019
Estimated completion	21 October 2021
Sites	2 locations across France

Drugs / interventions tested

thermode (TSA-II model)
Adapted Physical Activity
Physical activity

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 60, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fibromyalgia affects 1.4 now 2.2% of the general population whose symptom is the presence of widespread pain in all four quadrants of the body. Currently, there is no causal treatment of fibromyalgia syndrome. The aim of this study is the evaluation of a specific training program on controls of pain in fibromyalgia patients by balancing the stress axis. The primary endpoint is the improvement in the Visual Analogue Scale VAS difference) measured during the test of the thermode (difference between the average VAS measured between the 10th and 40th second of P1 and the average VAS measured between the 10th and 40th of the second P3) between D0 (3rd consultation) and M24 (5th consultation - end of study visit), which will be compared in the two groups..Salivary cortisol is also tested.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of a specific training programme on the neuromodulation of pain in female patient with fibromyalgia (DouFiSport): a 24-month, controlled, randomised, double-blind protocol.
Le Fur Bonnabesse A, Cabon M, L'Heveder G, Kermarrec A, et al · · 2019 · cited 6× · PMID 30782715 · DOI 10.1136/bmjopen-2018-023742

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02486965 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 22 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02486965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing